Otsuka Holdings
4578.T
#747
Rank
$31.23 B
Marketcap
$59.14
Share price
0.21%
Change (1 day)
2.73%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: $1.05 Billion USD

According to Otsuka Holdings 's latest financial reports the company's current earnings are $14.47 Billion USD. In 2023 the company made an earning of $1.05 Billion USD a decrease over its 2022 earnings that were of $1.32 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023$1.05 B-20.93%
2022$1.32 B-12.7%
2021$1.52 B-19.92%
2020$1.90 B13.9%
2019$1.66 B52.07%
2018$1.09 B11.22%
2017$0.98 B-36.03%
2016$1.54 B31.15%
2015$1.17 B
2013$2.44 B33.52%
2012$1.82 B-4.65%
2011$1.91 B45.53%
2010$1.31 B